Heart Failure
📧 Sign up to get email alerts when something new happens for Heart Failure.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-12-14Clinical Trial Update: Acute Effects of Beet Juice Consumption on Exercise Capacity in Heart Failure [Phase 1, Phase 2]
This clinical trial update reports results from Phase 1/2 studies evaluating the acute effects of beet juice on exercise capacity in heart f…
-
FDA approval · 2015-12-11FDA Approved: VALSARTAN — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for VALSARTAN submitted by Alembic Pharmaceuticals Limited.
-
CLINICAL_TRIALS withdrawal · 2015-12-11Clinical Trial Update: The Use of Tolvaptan to Prevent Renal Dysfunction in High Risk Patients With Heart Failure-Pilot Study [Phase 4]
A Phase 4 pilot trial evaluating tolvaptan to prevent renal dysfunction in high-risk heart failure patients has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-12-09Clinical Trial Update: Effects of Exenatide in Type 2 Diabetic Patients With Congestive Heart Failure [Phase 4]
A Phase 4 clinical trial evaluating the effects of exenatide in adults with type 2 diabetes mellitus and congestive heart failure has comple…
-
CLINICAL_TRIALS trial_result · 2015-12-08Clinical Trial Update: A Study of Triple-site Ventricular Pacing in Patients Who Have Not Responded to Conventional Dual Ventricular Site Cardiac Resynchronization Therapy [Phase 4]
This Phase 4 clinical trial update reports completion of a study evaluating triple-site ventricular pacing for heart failure patients who di…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-12-07Clinical Trial Update: Inspiratory Muscle and Peripheral Muscle Training in Chronic Heart Failure [NA]
The clinical trial examining inspiratory muscle and peripheral muscle training in chronic heart failure has completed.
-
CLINICAL_TRIALS research · 2015-12-04Clinical Trial Update: Transplantation of Autologous Cardiac Stem Cells in Ischemic Heart Failure [Phase 2]
This update concerns a Phase 2 trial evaluating transplantation of autologous cardiac stem cells for ischemic heart failure; no current stat…
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: Chronic Heart Failure - Cheyne Stokes Respiration - CS2 (3C-study) [NA]
The CS2/3C-study evaluating chronic heart failure with Cheyne-Stokes respiration has completed, as per ClinicalTrials.gov update.
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: Effects of Low-frequency Electrical Stimulation in Patients With Advanced HF [NA]
A clinical trial evaluating the effects of low-frequency electrical stimulation in patients with advanced heart failure has completed.
-
CLINICAL_TRIALS withdrawal · 2015-12-03Clinical Trial Update: Improving MEDication Adherence in Chronic Heart Failure Using a TELEmedicine Device (TELEMED-HF) [NA]
The TELEMED-HF trial evaluating a telemedicine device to improve medication adherence in chronic heart failure has been withdrawn.
-
CLINICAL_TRIALS research · 2015-12-03Clinical Trial Update: Patient Journey in Hospital With Acute Heart Failure
Clinical trial update related to patients with heart failure, with no results reported yet.
-
CLINICAL_TRIALS trial_result · 2015-12-02Clinical Trial Update: IMPACT-CABG Trial: IMPlantation of Autologous CD133+ sTem Cells in Patients Undergoing Coronary Artery Bypass Grafting [Phase 2]
Phase 2 trial evaluating autologous CD133+ stem cell therapy in patients undergoing coronary artery bypass grafting has completed.
-
CLINICAL_TRIALS trial_result · 2015-12-02Clinical Trial Update: Testing the Effects of Telehealth Monitoring on Rehospitalization and Self Care for Heart Failure Patients in Home Care [Phase 3]
Phase 3 clinical trial update on telehealth monitoring to reduce rehospitalization and improve self-care in heart failure patients receiving…
-
CLINICAL_TRIALS research · 2015-11-26Clinical Trial Update: Assessing the Safety and Bioactivity of SG1002 in Heart Failure Patients [Phase 1, Phase 2]
A Phase 1/2 clinical trial update evaluating the safety and bioactivity of SG1002 in patients with heart failure; current status is not disc…
-
FDA approval · 2015-11-25FDA Approved: QUINAPRIL — Supplemental Application (Cipla USA Inc.)
FDA approved a supplemental application for Quinapril by Cipla USA Inc., indicating an approval of an additional Quinapril product or labeli…
-
CLINICAL_TRIALS trial_result · 2015-11-25Clinical Trial Update: Inspiratory Muscle Training in Stroke Patients With Stable Congestive Heart Failure: a Prospective RCT. [NA]
A prospective randomized trial evaluating inspiratory muscle training in stroke patients with stable congestive heart failure has completed.
-
FDA approval · 2015-11-24FDA Approved: QUINAPRIL — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Quinapril hydrochloride from Aurobindo Pharma Limited, enabling the generic product Quinapril hy…
-
CLINICAL_TRIALS trial_result · 2015-11-24Clinical Trial Update: Effect of Targeting Left Ventricular Lead Position on the Rate of Response to Cardiac Resynchronization Therapy. [Phase 2, Phase 3]
This completed Phase 2/3 clinical trial evaluated whether optimizing the left ventricular lead position improves the response rate to cardia…
-
CLINICAL_TRIALS trial_result · 2015-11-24Clinical Trial Update: Torsion Optimization to Reduce Symptoms and Improve Outcomes in Non-responders [Phase 3]
Phase 3 clinical trial update on torsion optimization to reduce symptoms and improve outcomes in non-responders with heart failure.
-
CLINICAL_TRIALS trial_result · 2015-11-23Clinical Trial Update: Sodium Excretion of LCZ696 in Patients With Hypertension; Heart Failure and Healthy Volunteers [Phase 2]
Phase 2 results report on how LCZ696 (sacubitril/valsartan) affects sodium excretion in patients with hypertension, heart failure, and in he…
-
FDA approval · 2015-11-20FDA Approved: VALSARTAN — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved a supplemental application for valsartan submitted by Lupin Pharmaceuticals, Inc.
-
FDA approval · 2015-11-18FDA Approved: LISINOPRIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (GSMS, Incorporated)
FDA approved a supplemental application for the lisinopril and hydrochlorothiazide combination from GSMS, Incorporated.
-
CLINICAL_TRIALS trial_result · 2015-11-18Clinical Trial Update: Optimal Programming to Improve Mechanical Indices, Symptoms and Exercise in Cardiac Resynchronization Therapy. [Phase 4]
A Phase 4 clinical trial evaluating optimal programming of cardiac resynchronization therapy to improve mechanical indices, symptoms, and ex…
-
CLINICAL_TRIALS trial_result · 2015-11-18Clinical Trial Update: Study to Evaluate the Effectiveness of Cardiac Rehabilitation (Rehab) for Acute Decompensated Heart Failure Patients on 6 Minute Walk Test and Quality of Life [NA]
A clinical trial evaluating a cardiac rehabilitation program for heart failure patients was terminated. The study assessed outcomes using th…
-
CLINICAL_TRIALS withdrawal · 2015-11-17Clinical Trial Update: Pilot Study: Cardiovascular Events in High Risk Orthopedic Surgical Patients
A pilot trial evaluating cardiovascular events in high-risk orthopedic surgical patients has been withdrawn.